Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N
MNKD.OQ - MannKind Corp
MannKind Corp to Discuss Afrezza Pediatric Approval
May 29, 2026 / 08:30PM GMT
=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon, and welcome to the Mankind Corporation conference call to discuss the US FDA approval of the Freza in pediatrics.
As a reminder, this call is being recorded on May 29, 2026 and will be available for replay on the Mankind Corporation website shortly after this call for approximately 90 days.
This call will contain forward-looking statements. Such forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from these expectations. For further information on the company's risk factors, please see the Form 10-Q for the period ended March 31st, 2026, this morning's press release, and the slides prepared for this presentation.
Joining us
Trustpilot
